Literature DB >> 24696278

[Antibiotic therapy: impact and resistance].

S Weiler1, N Corti.   

Abstract

BACKGROUND: Many achievements in modern medicine, such as in transplantation medicine, cancer therapy, surgery, and intensive care medicine would have been impossible without effective treatment of bacterial infections. Antibiotic resistance is on the rise; the reasons for this are complex and vary greatly.
OBJECTIVE: Knowledge about the impact of antibiotics and mechanisms of antibiotic resistance, which are the cornerstones of calculated and targeted antibiotic therapy, is imperative.
RESULTS: This review describes the pharmacodynamics of relevant antibiotics in emergency and intensive care medicine. Commonly resistant bacteria with clinical relevance and the respective mechanisms of resistance are highlighted. Furthermore, the use of antiinfectives for reserve treatment of severe infections is discussed.
CONCLUSION: Understanding the mechanisms of resistance and effects of antibiotics are fundamental for efficient and successful treatment of bacterial infections and for the reduction of resistant species.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696278     DOI: 10.1007/s00063-013-0307-2

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  22 in total

1.  Daptomycin dose-effect relationship against resistant gram-positive organisms.

Authors:  Raymond Cha; Richard G Grucz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Mechanisms of fluoroquinolone resistance.

Authors:  David C. Hooper
Journal:  Drug Resist Updat       Date:  1999-02       Impact factor: 18.500

Review 3.  Quinupristin/dalfopristin: a therapeutic review.

Authors:  D R Allington; M P Rivey
Journal:  Clin Ther       Date:  2001-01       Impact factor: 3.393

Review 4.  Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

Authors:  S S Patel; J A Balfour; H M Bryson
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 5.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

7.  Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.

Authors:  Nasia Safdar; Jo Handelsman; Dennis G Maki
Journal:  Lancet Infect Dis       Date:  2004-08       Impact factor: 25.071

Review 8.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.

Authors:  Mical Paul; Ishay Benuri-Silbiger; Karla Soares-Weiser; Leonard Leibovici
Journal:  BMJ       Date:  2004-03-02

9.  Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.

Authors:  Larry M Baddour; Victor L Yu; Keith P Klugman; Charles Feldman; Ake Ortqvist; Jordi Rello; Arthur J Morris; Carlos M Luna; David R Snydman; Wen Chien Ko; M Bernadete F Chedid; David S Hui; Antoine Andremont; Christine C C Chiou
Journal:  Am J Respir Crit Care Med       Date:  2004-06-07       Impact factor: 21.405

Review 10.  Parenteral aminoglycoside therapy. Selection, administration and monitoring.

Authors:  C R Kumana; K Y Yuen
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.